Product/Composition:- | Erythromycin tablets/ Capsules |
---|---|
Strength:- | 250 mg, 500 mg, 600 mg |
Form:- | Oral Tablets/Capsules |
Reference Brands:- | Erythrocin, Erythrocin V, Erythrocin Stearate(US) |
MOQ | As per the manufacturer batch size |
Get Quote Send Enquiry on WhatsApp |
Erythromycin inhibits bacterial protein synthesis by binding to the 50S ribosomal subunit, preventing translocation. It is effective against respiratory, skin, and soft tissue infections. Benefits include reliable, broad-spectrum activity, good tissue penetration, and convenient oral dosing, making it a trusted choice for treating various bacterial infections.
Erythromycin tablets are approved in the EU and US for treating respiratory, skin, and soft tissue bacterial infections. In the EU, brands like Erythrocin and generics are regulated by EMA, supported by dossiers demonstrating safety, efficacy, and quality standards. In the US, FDA approval relies on extensive clinical data; generic formulations are widely available. Both regions require detailed dossiers, including clinical trial results, manufacturing standards, and pharmacovigilance plans, for approval and ongoing safety monitoring. For expert assistance with regulatory dossiers, compliance, and registration, visit PharmaTradz. We support seamless market access for erythromycin tablets, ensuring adherence to European and US standards for safe, effective antibiotic therapy.